Rosa David A
- SEC CIK
- 0001540354
No open-market purchases or sales filed in the past year.
Current role at each company
- NMTC Neuroone Medical Technologies CorpCEO & Presidentas of Aug 28, 2026
- BRTX BioRestorative Therapies, Inc.Directoras of Feb 19, 2025
- HCTI Healthcare Triangle, Inc.Directoras of Mar 13, 2024
- BTCY Biotricity Inc.Directoras of Mar 15, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Rosa David A as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
NMTC Neuroone Medical Technologies Corp
CEO & President1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 7, 2025 (view filing) | Apr 4 | 3 days | Rosa David ACEO and President | PPurchase | +100.0K | $0.50 | +$50.0K | +9.4%1.16M after |
BTCY Biotricity Inc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 13, 2021 (view filing) | Oct 7-11 | 6 daysLate | Rosa David ADirector | SSale | −30.0K | $3.11 | −$93.5K | −19.4%125.0K after | 3 lots |
| Sep 29, 2021 (view filing) | Sep 15-16 | 14 daysLate | Rosa David ADirector | SSale | −41.2K | $3.41 | −$140.4K | −21.0%155.0K after | 2 lots |